Our recent analysis titled "Continuous Renal Replacement Therapy Market Forecast to 2030 - Global Analysis - Product, Modality, End User, and Geography" indicates that the market was valued at approximately US$ 1.42 billion in 2022 and is projected to grow to US$ 2.75 billion by 2030. This growth represents an estimated compound annual growth rate (CAGR) of 8.7% from 2022 through 2030.
Continuous renal replacement therapy (CRRT) has emerged as the preferred dialysis method for pediatric patients suffering from acute kidney injury (AKI) in intensive care units (ICUs). The criteria for renal replacement therapy in children have evolved significantly, reflecting the diverse range of pediatric illnesses. The applications of CRRT have broadened, demonstrating its effectiveness not only for renal issues but also for various non-renal conditions, particularly in critically ill infants. For example, Medtronic's Carpediem system is specifically designed for low-weight patients, claiming to meet the unique needs of the most vulnerable individuals. Additionally, Baxter's PRISMASOL and PHOXILLUM solutions serve as replacement fluids in CRRT, effectively replenishing plasma volume lost through ultrafiltration and addressing electrolyte and acid-base imbalances in both pediatric and adult patients. Consequently, the rising demand for CRRT devices tailored for children is a significant driver of growth in the continuous renal replacement therapy market.
Insights Based on Product in the Continuous Renal Replacement Therapy Market
The continuous renal replacement therapy market is categorized by product into several segments: dialysates and replacement fluids, disposables, bloodline sets and tubes, CRRT systems, and hemofilters. In 2022, the CRRT systems segment captured the largest market share. However, the hemofilters segment is anticipated to experience the highest CAGR during the period from 2022 to 2030. Hemofilters utilize a hollow-fiber membrane that regulates the volume of fluids and solutes that are removed. By filtering out waste products, electrolytes, and other substances, CRRT hemofilters replicate some of the kidney's functions. Furthermore, they assist in restoring fluid balance and maintaining acid-base equilibrium through their operational capabilities.
Insights Based on End User in the Continuous Renal Replacement Therapy Market
When examining the continuous renal replacement therapy market by end user, the segments include hospitals, ambulatory care centers, home care, and others. The hospital segment was the leading contributor to the market share in 2022. Notably, the home care segment is projected to achieve the highest CAGR from 2022 to 2030. According to the American Hospital Association, there were 5,157 community hospitals, 206 federal government hospitals, and 107 other hospitals in the United States as of 2023. The increasing elderly population and the significant rise in hospital admissions due to AKI are primary factors driving the demand for CRRT systems within hospital settings.
Research Sources
In preparing the report on the continuous renal replacement therapy market, several key secondary sources were utilized, including publications from the National Institutes of Health, investor reports from relevant companies, and data from the World Health Organization. These sources provided valuable insights and data to support the analysis of market trends and forecasts.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 Market Definition, Assumptions and Limitations
1.3 Market Segmentation
2. Executive Summary
2.1 Key Insights
2.2 Market Attractiveness Analysis
3. Research Methodology
4. Continuous Renal Replacement Therapy Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
4.3.1 List of Vendors in the Value Chain
5. Continuous Renal Replacement Therapy Market - Key Market Dynamics
5.1 Key Market Drivers
5.2 Key Market Restraints
5.3 Key Market Opportunities
5.4 Future Trends
5.5 Impact Analysis of Drivers and Restraints
6. Continuous Renal Replacement Therapy Market - Global Market Analysis
6.1 Continuous Renal Replacement Therapy - Global Market Overview
6.2 Continuous Renal Replacement Therapy - Global Market and Forecast to 2030
7. Continuous Renal Replacement Therapy Market - Revenue Analysis (USD Million) - By Product, 2020-2030
7.1 Overview
7.2 Dialysates and Replacement Fluids
7.3 Disposables
7.4 Bloodline Sets and Tubes
7.5 Hemofilters
7.6 CRRT Systems
8. Continuous Renal Replacement Therapy Market - Revenue Analysis (USD Million) - By Modality, 2020-2030
8.1 Overview
8.2 Continuous venovenous hemofiltration (CVVH)
8.3 Continuous venovenous hemodiafiltration (CVVHDF)
8.4 Continuous venovenous hemodialysis (CVVHD)
8.5 Slow continuous ultrafiltration (SCUF)
9. Continuous Renal Replacement Therapy Market - Revenue Analysis (USD Million) - By End User, 2020-2030
9.1 Overview
9.2 Hospital
9.3 Ambulatory care
9.4 Homecare
9.5 Others
10. Continuous Renal Replacement Therapy Market - Revenue Analysis (USD Million), 2020-2030 - Geographical Analysis
10.1 North America
10.1.1 North America Continuous Renal Replacement Therapy Market Overview
10.1.2 North America Continuous Renal Replacement Therapy Market Revenue and Forecasts to 2030
10.1.3 North America Continuous Renal Replacement Therapy Market Revenue and Forecasts and Analysis - By Product
10.1.4 North America Continuous Renal Replacement Therapy Market Revenue and Forecasts and Analysis - By Modality
10.1.5 North America Continuous Renal Replacement Therapy Market Revenue and Forecasts and Analysis - By End User
10.1.6 North America Continuous Renal Replacement Therapy Market Revenue and Forecasts and Analysis - By Countries
10.1.6.1 United States Continuous Renal Replacement Therapy Market
10.1.6.1.1 United States Continuous Renal Replacement Therapy Market, by Product
10.1.6.1.2 United States Continuous Renal Replacement Therapy Market, by Modality
10.1.6.1.3 United States Continuous Renal Replacement Therapy Market, by End User
10.1.6.2 Canada Continuous Renal Replacement Therapy Market
10.1.6.2.1 Canada Continuous Renal Replacement Therapy Market, by Product
10.1.6.2.2 Canada Continuous Renal Replacement Therapy Market, by Modality
10.1.6.2.3 Canada Continuous Renal Replacement Therapy Market, by End User
10.1.6.3 Mexico Continuous Renal Replacement Therapy Market
10.1.6.3.1 Mexico Continuous Renal Replacement Therapy Market, by Product
10.1.6.3.2 Mexico Continuous Renal Replacement Therapy Market, by Modality
10.1.6.3.3 Mexico Continuous Renal Replacement Therapy Market, by End User
Note - Similar analysis would be provided for below mentioned regions/countries
10.2 Europe
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 Spain
10.2.5 United Kingdom
10.2.6 Rest of Europe
10.3 Asia-Pacific
10.3.1 Australia
10.3.2 China
10.3.3 India
10.3.4 Japan
10.3.5 South Korea
10.3.6 Rest of SouthEast Asia
10.4 Middle East and Africa
10.4.1 South Africa
10.4.2 U.A.E
10.4.3 Rest of Middle East and Africa
10.5 South and Central America
10.5.1 Brazil
10.5.2 Argentina
10.5.3 Rest of South and Central America
11. Industry Landscape
11.1 Mergers and Acquisitions
11.2 Agreements, Collaborations, Joint Ventures
11.3 New Product Launches
11.4 Expansions and Other Strategic Developments
12. Competitive Landscape
12.1 Heat Map Analysis by Key Players
12.2 Company Positioning and Concentration
13. Continuous Renal Replacement Therapy Market - Key Company Profiles
13.1 Baxter International Inc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
Note - Similar information would be provided for below list of companies
13.2 Asahi Kasei
13.3 Fresenius Medical Care
13.4 Medica S.p.A.
13.5 Medtronic Plc
13.6 B. Braun
13.7 Nikkiso Co Ltd
13.8 Toray Medical Co Ltd
13.9 Infomed SA
13.10 Quanta Dialysis Technologies Inc
14. Appendix
14.1 Glossary
14.2 About
14.3 Market Intelligence Cloud
LIST OF TABLES
LIST OF FIGURES
The List of Companies - Continuous Renal Replacement Therapy Market
Baxter International Inc
Asahi Kasei
Fresenius Medical Care
Medica S.p.A.
Medtronic Plc
B. Braun
Nikkiso Co Ltd
Toray Medical Co Ltd
Infomed SA
Quanta Dialysis Technologies Inc
